Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

CHANGZHOU PHARM

  • FDA Approval
  • Sept. 11, 2023, 11:45 UTC
  • 27
  • 0 comments

FDA approve DOXYCYCLINE HYCLATE

Comment Full text

MANKIND PHARMA

  • FDA Approval
  • Sept. 08, 2023, 20:45 UTC
  • 31
  • 0 comments

FDA approve ALOSETRON HYDROCHLORIDE

Comment Full text

SEBELA IRELAND LTD

  • FDA Approval
  • Sept. 08, 2023, 20:45 UTC
  • 31
  • 0 comments

FDA approve ALOSETRON HYDROCHLORIDE

Comment Full text

RISING

  • FDA Approval
  • Sept. 08, 2023, 20:45 UTC
  • 30
  • 0 comments

FDA approve ALOSETRON HYDROCHLORIDE

Comment Full text

CELLTRION

  • FDA Approval
  • Sept. 08, 2023, 20:14 UTC
  • 31
  • 0 comments

FDA approve ADALIMUMAB-AATY

Comment Full text

PF PRISM CV

  • FDA Approval
  • Sept. 08, 2023, 17:48 UTC
  • 30
  • 0 comments

FDA approve CRIZOTINIB

Comment Full text

EMD SERONO INC

  • FDA Approval
  • Sept. 07, 2023, 11:37 UTC
  • 32
  • 0 comments

FDA approve AVELUMAB

Comment Full text

AMNEAL PHARMS LLC

  • FDA Approval
  • Sept. 07, 2023, 11:37 UTC
  • 32
  • 0 comments

FDA approve SPIRONOLACTONE

Comment Full text

PFIZER

  • FDA Approval
  • Sept. 07, 2023, 11:37 UTC
  • 31
  • 0 comments

FDA approve PALBOCICLIB

Comment Full text

BIOGEN INC

  • FDA Approval
  • Aug. 31, 2023, 20:14 UTC
  • 32
  • 0 comments

FDA approve ADUCANUMAB-AVWA

Comment Full text
  • Previous
  • 682
  • 683
  • 684
  • 685
  • 686
  • Next

Search

News categories

  • Technical Exchange News(12002)
  • Event(5170)
  • SEC News(249095)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(149701)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin